Device Trial Radar · NCT00393549
NeuroPath Comparative Validation Study Plan
Last checked: Nov 20, 2026Latest source record: Jun 6, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
200
Planned (sponsor's estimate)
Start
Aug 2006
Primary completion
Not stated
Study completion Dec 2006
Sponsor
- Lead sponsor
- Excel-Tech Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 30, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.
Conditions
- Carpal Tunnel Syndrome (CTS)
Interventions
NeuroPathDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Validity of the NeuroPath
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
SunCoast Neuroscience Associateion
St. Petersburg, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.